跳至主要内容
临床试验/NCT05378529
NCT05378529已完成不适用

A Multicenter, Cross-sectional Study to Characterize the Distribution of Lipoprotein(a) Levels Among Patients With Documented History of Atherosclerotic Cardiovascular Disease

Amgen1456 个研究点 分布在 3 个国家目标入组 39,480 人开始时间: 2022年4月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Amgen
入组人数
39,480
试验地点
1,456
主要终点
Number of participants with elevated Lp(a) with documented history of ASCVD

研究概览

简要总结

The purpose of this study is to characterize the distribution of lipoprotein(a) (Lp(a)) levels among participants with a history of ASCVD as defined by their medical history and is 2-fold:

  • Evaluate the distribution of Lp(a) value in the overall participants with documented history of ASCVD
  • Evaluate the distribution of Lp(a) value in participants with documented history of ASCVD by demographics and regions

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Signed informed consent
  • History of ASCVD

排除标准

  • Participants known to be currently receiving investigational drug in a clinical study
  • Participants with a diagnosis of end-stage renal disease or requiring dialysis
  • Participants who have received lipoprotein apheresis to reduce Lp(a) within 3 months prior to enrollment

结局指标

主要结局

Number of participants with elevated Lp(a) with documented history of ASCVD

时间窗: Up to approximately 2 weeks

次要结局

  • Lp(a) Levels(Up to approximately 2 weeks)
  • Lp(a) Levels stratified by demographics and region(Up to approximately 2 weeks)

研究者

发起方
Amgen
申办方类型
Industry
责任方
Sponsor

研究点 (1456)

Loading locations...

相似试验

A Cross-sectional Study of Lipoprotein(a) Levels in... | 临床试验